334 related articles for article (PubMed ID: 21044939)
1. [Carcinoid tumors].
Pregun I; Bodoky G; Rácz K; Tulassay Z
Orv Hetil; 2010 Nov; 151(46):1885-94. PubMed ID: 21044939
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacologic therapy for neuroendocrine tumours].
Petrányi A; Bodoky G
Orv Hetil; 2011 Mar; 152(10):379-91. PubMed ID: 21354954
[TBL] [Abstract][Full Text] [Related]
3. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
4. Carcinoid tumors of the gastrointestinal tract.
Ghevariya V; Malieckal A; Ghevariya N; Mazumder M; Anand S
South Med J; 2009 Oct; 102(10):1032-40. PubMed ID: 19738517
[TBL] [Abstract][Full Text] [Related]
5. Systemic Therapies for Advanced Gastrointestinal Carcinoid Tumors.
Mulvey CK; Bergsland EK
Hematol Oncol Clin North Am; 2016 Feb; 30(1):63-82. PubMed ID: 26614369
[TBL] [Abstract][Full Text] [Related]
6. Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors.
Khan MU; Morse M; Coleman RE
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):441-54. PubMed ID: 19088697
[TBL] [Abstract][Full Text] [Related]
7. [Carcinoid tumors].
Tóth M; Prónai L; Németh AM; Tulassay Z
Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
Uprety D; Halfdanarson TR; Molina JR; Leventakos K
Curr Treat Options Oncol; 2020 Aug; 21(11):86. PubMed ID: 32862320
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal carcinoid tumors: diagnosis and treatment.
Stamatakos M; Kontzoglou K; Sargedi C; Tsaknaki S; Iannescu R; Safioleas C; Kaitanidi V; Safioleas M
Chirurgia (Bucur); 2010; 105(6):759-66. PubMed ID: 21351698
[TBL] [Abstract][Full Text] [Related]
10. [Effective treatment of a hormonally inactive carcinoid tumour with somatostatin analogues: application of serum chromogranin-A for clinical follow-up].
Igaz P; Rácz K; Tulassay Z
Orv Hetil; 2007 Dec; 148(49):2343-6. PubMed ID: 18048114
[TBL] [Abstract][Full Text] [Related]
11. Management of advanced and/or metastatic carcinoid tumors: historical perspectives and emerging therapies.
Nandy N; Dasanu CA
Expert Opin Pharmacother; 2013 Aug; 14(12):1649-58. PubMed ID: 23746075
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal carcinoids: the evolution of diagnostic strategies.
Modlin IM; Latich I; Zikusoka M; Kidd M; Eick G; Chan AK
J Clin Gastroenterol; 2006 Aug; 40(7):572-82. PubMed ID: 16917396
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid tumors--somatostatine in the diagnosis and therapy.
Kinova S; Duris I; Kratochvilova E; Ondrejka P; Payer J
Bratisl Lek Listy; 2002; 103(3):108-12. PubMed ID: 12190042
[TBL] [Abstract][Full Text] [Related]
14. [Current concepts on diagnosis and treatment of carcinoid].
Krysiak R; Okopień B; Herman ZS
Przegl Lek; 2007; 64(2):103-10. PubMed ID: 17892042
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mTOR in carcinoid tumors.
Grozinsky-Glasberg S; Pavel M
Target Oncol; 2012 Sep; 7(3):189-95. PubMed ID: 22886906
[TBL] [Abstract][Full Text] [Related]
16. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
Guadalupe E; Deshpande HA; Stein SM
Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
[TBL] [Abstract][Full Text] [Related]
17. Efficient symptomatic control of carcinoid tumors with somatostatin in patients with disease progression under alpha-interferon therapy.
Boehme MW; Schmidt-Gayk H; Bihl H; Eisenhut M; Herfarth CH; Kommere B; Raeth U
Hepatogastroenterology; 1995; 42(6):1053-61. PubMed ID: 8847018
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
[TBL] [Abstract][Full Text] [Related]
19. [Neuroendocrine tumors of the gastrointestinal tract].
Arnold C
Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
[TBL] [Abstract][Full Text] [Related]
20. mTOR inhibition, a potential novel approach for bronchial carcinoids.
Dong M; Yao JC
Endocr Relat Cancer; 2011 Jun; 18(3):C15-8. PubMed ID: 21427170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
